Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPA-2 alfimeprase versus placebo in acute peripheral arterial occlusion
2004-002950-67Phase 3Completed
- Sponsor
- Nuvelo
- Start
- Feb 2005
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute limb ischaemia (ALI) comparing Alfimeprase with Placebo (2 arms). Primary endpoint: 30-day open vascular surgery-free rate. Started Feb 2005; status: completed.
02
Drugs
alfimeprase
03
Conditions
Acute limb ischaemia (ALI)
Beyond the preview
Go deeper on 2004-002950-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002950-67.